Table 2.
Factor | RFS
|
CSS
|
OS
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate
|
Multivariate
|
Univariate
|
Multivariate
|
Univariate
|
Multivariate
|
||||||||
HR | P-value | HR | 95% CI | P-value | HR P-value | HR | 95% CI | P-value | HR P-value | HR | 95% CI | P-value | |
T stage (2–3 vs 4) | 2.87 | 0.02 | 6.30 | 1.91–20.74 | 0.002 | 7.24 0.01 | 20.31 | 2.37–174.23 | 0.006 | 3.09 0.02 | 3.25 | 1.15–9.16 | 0.026 |
M-CSF (high vs low) | 1.68 | 0.31 | 1.63 0.46 | 1.15 0.78 | |||||||||
G-CSF (low vs high) | 2.91 | 0.02 | 9.62 | 2.87–37.34 | 0.001 | 4.42 0.02 | 6.33 | 1.11–22.54 | 0.014 | 3.09 0.031 | |||
GM-CSF (high vs low) | 3.32 | 0.01 | 10.35 | 3.04–35.25 | 0.001 | 3.89 0.04 | 8.20 | 1.66–40.45 | 0.01 | 2.58 0.04 | 3.48 | 1.20–10.09 | 0.022 |
Abbreviations: RFS, recurrence-free survival; CSS, cancer-specific survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; M-CSF, macrophage colony-stimulating factor; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte macrophage colony-stimulating factor.